Form 4 filed by Mainolfi Nello
Mainolfi Nello filed this Form 4 on Kymera Therapeutics, Inc. with 8 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-01 21:20:12 UTC.
- Accession
- 0001193125-26-410839
- Filer
- CIK 1821189
- Filed
- 2026-10-01
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Kymera Therapeutics, Inc. (CIK 1815442)
- Mainolfi Nello director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-01 | M exercised | +30,000 | $2.08 | 696,568 | D |
| Common Stock | 2026-10-01 | S sold | -3,525 | $111.44 | 693,043 | D |
| Common Stock | 2026-10-01 | S sold | -5,506 | $112.42 | 687,537 | D |
| Common Stock | 2026-10-01 | S sold | -4,876 | $113.24 | 682,661 | D |
| Common Stock | 2026-10-01 | S sold | -7,601 | $114.43 | 675,060 | D |
| Common Stock | 2026-10-01 | S sold | -8,230 | $115.4 | 666,830 | D |
| Common Stock | 2026-10-01 | S sold | -262 | $116.12 | 666,568 | D |
| Stock Option (Right to Buy) derivative | 2026-10-01 | M exercised | -30,000 | $0 | 60,000 | D |